Marc van Dijk

UCB Pharma (Belgium) — Belgium

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index7.0kcitations60works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Structure and Dynamics(21), Enzyme Structure and Function(9), Computational Drug Discovery Methods(8), DNA and Nucleic Acid Chemistry(8), Bioinformatics and Genomic Networks(6)

Publications60 total

On the two-step hybrid design for augmenting randomized trials using real-world data
Statistics in Biopharmaceutical Research·2025Open Access
On the two-step hybrid design for augmenting randomized trials using real-world data
arXiv (Cornell University)·2025Open Access
OFraMP: a fragment-based tool to facilitate the parametrization of large molecules
Journal of Computer-Aided Molecular Design·2023· 18 citedOpen Access
Uncovering Anticancer Bioactives from Potentilla nepalensis: An Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics, and MMGBSA-Based Approach to Therapeutic Target Identification
Pharmaceutical Sciences and Drug Design·2023Open Access
Recent Developments in Linear Interaction Energy Based Binding Free Energy Calculations
Frontiers in Molecular Biosciences·2020· 33 citedOpen Access
Valkuilen bij Living Labs vermijden
Research Publications (Maastricht University)·2020Open Access
A Comparative Linear Interaction Energy and MM/PBSA Study on SIRT1–Ligand Binding Free Energy Calculation
Journal of Chemical Information and Modeling·2019· 91 citedOpen Access
A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease
Clinical Immunology·2019· 23 citedOpen Access
Abstract 3825: INCAGN02390, a novel antagonist antibody that targets the co-inhibitory receptor TIM-3
Cancer Research·2018· 18 cited
Abstract 5861: RX-3117 promotes epigenetic effects in cancer cells through enhanced degradation of DNMT1
Cancer Research·2018
Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals
Current Drug Metabolism·2018· 17 citedOpen Access
HADDOCK
2018· 1 cited
Drug toxicity profiling of a Saccharomyces cerevisiae deubiquitinase deletion panel shows that acetaminophen mimics tyrosine
Toxicology in Vitro·2017· 5 citedOpen Access
eTOX ALLIES: an automated pipeLine for linear interaction energy-based simulations
Journal of Cheminformatics·2017· 8 citedOpen Access
Binding free energy predictions of farnesoid X receptor (FXR) agonists using a linear interaction energy (LIE) approach with reliability estimation: application to the D3R Grand Challenge 2
Journal of Computer-Aided Molecular Design·2017· 15 citedOpen Access
Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors
Journal of Chemical Information and Modeling·2017· 25 citedOpen Access
Sense and Simplicity in HADDOCK Scoring: Lessons from CASP‐CAPRI (page 418)
Proteins Structure Function and Bioinformatics·2017· 35 citedOpen Access
Sense and simplicity in <scp>HADDOCK</scp> scoring: Lessons from <scp>CASP‐CAPRI</scp> round 1
Proteins Structure Function and Bioinformatics·2016· 62 citedOpen Access
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
Journal of Molecular Biology·2015· 2.9k citedOpen Access
Mass Spec Studio for Integrative Structural Biology
Structure·2014· 108 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Alexandre M. J. J. Bonvin(20), Panagiotis L. Kastritis(9), Sjoerd J. de Vries(9), Ezgi Karaca(8), Adrien S. J. Melquiond(8), Daan P. Geerke(7), Tsjerk A. Wassenaar(6), Nico Vermeulen(6), Gydo C. P. van Zundert(5), João Rodrigues(5), Mikaël Trellet(5), Carl Schmitz(4), Rolf Boelens(4), Eko Aditya Rifai(4), Petrus J.M. van der Slot(4), Klaus J. Boller(4), Micha Werner(3), Jaap Schellekens(3), Gijs van der Schot(3), Christophe Schmitz(3)